Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Winde Jorissen, Lieven Annemans, Nicolas Louis, Andreas Nilsson & Michael Willis. (2022) Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium. Acta Clinica Belgica 77:6, pages 945-954.
Read now
Read now
Beatriz Rodriguez-Sanchez, Isaac Aranda-Reneo, Juan Oliva-Moreno & Julio Lopez-Bastida. (2021) Assessing the Effect of Including Social Costs in Economic Evaluations of Diabetes-Related Interventions: A Systematic Review. ClinicoEconomics and Outcomes Research 13, pages 307-334.
Read now
Read now
Articles from other publishers (13)
Johan Jendle & Yves Reznik. (2023) Use of insulin pumps and closed‐loop systems among people living with diabetes: A narrative review of clinical and cost‐effectiveness to enable access to technology and meet the needs of payers. Diabetes, Obesity and Metabolism 25:S2, pages 21-32.
Crossref
Crossref
Titas Biswas, Biplab Kumar Behera & Nithar Ranjan Madhu. 2023. Advances in Diabetes Research and Management. Advances in Diabetes Research and Management
111
136
.
Aideen Daly & Roman Hovorka. (2021) Technology in the management of type 2 diabetes: Present status and future prospects. Diabetes, Obesity and Metabolism.
Crossref
Crossref
Francisco J. Barrera, Freddy JK. Toloza, Oscar J. Ponce, Jorge A. Zuñiga-Hernandez, Larry J. Prokop, Nilay D. Shah, Gordon Guyatt, Rene Rodriguez-Gutierrez & Victor M. Montori. (2020) The validity of cost-effectiveness analyses of tight glycemic control. A systematic survey of economic evaluations of pharmacological interventions in patients with type 2 diabetes. Endocrine 71:1, pages 47-58.
Crossref
Crossref
Erika Pedone, Andrea Laurenzi, Agnese Allora, Andrea Mario Bolla & Amelia Caretto. (2020) Insulin pump therapy and continuous glucose monitoring in adults with type 2 diabetes: where are we now?. Exploration of Medicine 1:5, pages 314-330.
Crossref
Crossref
Judith J. Gout-Zwart, Lisa A. de Jong, Lisanne Saptenno & Maarten J. Postma. (2019) Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The Netherlands. PharmacoEconomics - Open 4:2, pages 321-330.
Crossref
Crossref
Yune Mou, Delin Ma, Jianhua Zhang, Jing Tao, Wentao He, Wenjun Li, Yiming Mu & Xuefeng Yu. (2019) Continuous subcutaneous insulin infusion reduces the risk of postoperative infection. Journal of Diabetes 12:5, pages 396-405.
Crossref
Crossref
Alexander V. van Schoonhoven, Judith J. Gout-Zwart, Marijke J. S. de Vries, Antoinette D. I. van Asselt, Evgeni Dvortsin, Pepijn Vemer, Job F. M. van Boven & Maarten J. Postma. (2019) Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands: A systematic review. PLOS ONE 14:9, pages e0221856.
Crossref
Crossref
Stephané Roze, Jayne Smith-Palmer, Alexis Delbaere, Karita Bjornstrom, Simona de Portu, William Valentine & Mikko Honkasalo. (2019) Cost-Effectiveness of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections in Patients with Poorly Controlled Type 2 Diabetes in Finland. Diabetes Therapy 10:2, pages 563-574.
Crossref
Crossref
Yves Reznik & Emilie Deberles. 2019. Handbook of Diabetes Technology. Handbook of Diabetes Technology
23
36
.
Peter Wahlqvist, Jay Warner & Robert Morlock. (2018) Cost-effectiveness of Simple Insulin Infusion Devices Compared to Multiple Daily Injections in Uncontrolled Type 2 Diabetics in the United States Based on a Simulation Model. Journal of Health Economics and Outcomes Research, pages 84-95.
Crossref
Crossref
Peter Wahlqvist, Jay Warner & Robert Morlock. (2018) Cost-effectiveness of Simple Insulin Infusion Devices Compared to Multiple Daily Injections in Uncontrolled Type 2 Diabetics in the United States Based on a Simulation Model. Journal of Health Economics and Outcomes Research 6:1, pages 84-95.
Crossref
Crossref
John C. Pickup, Yves Reznik & Alex J. Sutton. (2017) Glycemic Control During Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Insulin Injections in Type 2 Diabetes: Individual Patient Data Meta-analysis and Meta-regression of Randomized Controlled Trials. Diabetes Care 40:5, pages 715-722.
Crossref
Crossref